Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

3L-HeCoMe

Financiado

Advanced manufacturing process to obtain a partially Bio Resorbable Adhesive Non...

Advanced manufacturing process to obtain a partially Bio Resorbable Adhesive Non Adhesive Triple Layer Mesh for intra peritoneal Hernia Containment 3L-HeCoMe aims to provide efficient and effective industrial solutions to innovate the production processes and products for hernia containment. Ventral hernia repairs in Europe are 400.000/year, but post-operative complications s... ver más

30/11/2015

Herniamesh

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

HERNIAMESH SRL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-11-30

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

NMP-25-2014-1: Accelerating the uptake of nanotechnologies, advanced materials or advanced manufacturing and processing technologies by SMEs

I+D

Cerrada hace 10 años

0% 70% 100%

3 Participantes

Herniamesh

50.00K€ | Lider

MACRESAC

204.77K€ | Participante

Tissuemed Ltd

N.D. | Participante

Últimas noticias

01-12-2024: REDES En las últimas 48 horas el Organismo REDES ha otorgado 1337 concesiones

01-12-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

01-12-2024: AEI En las últimas 48 horas el Organismo AEI ha otorgado 23 concesiones

Duración del proyecto: 6 meses Fecha Inicio: 2015-05-28
Fecha Fin: 2015-11-30

Líder del proyecto

HERNIAMESH SRL

TRL 4-5

Presupuesto del proyecto 71K€

Descripción del proyecto 3L-HeCoMe aims to provide efficient and effective industrial solutions to innovate the production processes and products for hernia containment. Ventral hernia repairs in Europe are 400.000/year, but post-operative complications still occur, namely recurrence due to prosthetic displacement and adhesions between viscera and prosthetic surfaces. Considering estimated costs for each ventral hernia repair in Europe, costs due only to recurrence amount to 36.732.000 €/year. The main aim of 3L-HeCoMe Feasibility Study(FS) is the development of an innovative process supported by enabling technologies derived from other applications and by the use of advanced materials to produce a unique medical device for the Intraperitoneal Treatment of Abdominal Wall Hernias (IPTAWH). The produced IPTAWH medical device (IPTAWH-MD) aims at preventing post-surgery problems and avoiding, or decreasing, use of mechanical surgery instruments for the mesh fixation. The IPTAWH-MD will reduce the surgical duration and costs, thanks to the following characteristics: ‐ chemical adhesive properties to parietal tissues ‐ anti-adhesion properties to viscera ‐ adequate mechanical properties, ‐ partial bioresorption. FS objectives: ‐ investigate technical development, process customization and applicability ‐ qualify 3L-HeCoMe process production output and constituting materials ‐ assess market potential and penetration routes Final users are surgeons oriented towards simplified, faster and mininvasive procedure, in the global market, which amounts to about USD 500 million and has an estimated CAGR of 7.5%, bringing to 700 million in 2019. The resulting MD will substitute actual products, giving a solid position to the SME in global markets and increasing the income, with potential sales of 259.000 – 452.000 €/year from year 1 to 5. 3L-HeCoMe addresses societal issues avoiding hernia operation recurrence, improving quality of life of patients by reducing hospitalization and reducing healthcare

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores